The PSA Screening for HIM Act (H.R. 1826/S. 2821)
The PSA Screening for HIM Act (H.R. 1826/S. 2821) would remove out-of-pocket costs for prostate cancer screening for those at highest risk for the disease.
In the United States, colorectal cancer (CRC) is the third leading cause of cancer-related deaths in men and in women, and the second most common cause of cancer deaths when men and women are combined. Despite advancements in screening and treatment, CRC does not affect every community the same. New CRC cases (incidence) and deaths (mortality) vary substantially by race, ethnicity, socioeconomic status, and geography.